PharmiWeb.com - Global Pharma News & Resources
13-Apr-2022

Chromatography Software Market is estimated to increase at a steady CAGR of 7.8%, reaching US$ 1.1 Bn by 2032

According to an analysis by Future Market Insights (FMI), the chromatography software market is expected to be valued at US$ 1.1 Bn in 2032, with an 7.8% CAGR during the forecast period.

The adoption of chromatography software is due to an increase in the demand for chromatography techniques in research and development activities across several business verticals. For example, increased food safety rules and an increasing focus on pharmaceutical R&D contribute to the growing need for chromatography systems and software.

The expanding need for chromatography software is fuelled by increased pharmaceutical research activities, the rising prevalence of diseases requiring diagnosis and testing, and increased worries about food and safety pharmaceuticals.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14319
Furthermore, due to the increased use of chromatography techniques to study medications and their usefulness as a treatment, the COVID-19 outbreak has boosted the demand for chromatography systems. As a result, the stock market has risen during the pandemic.

Remdesivir was measured in the blood plasma of a COVID-19 infected patient using liquid chromatography combined with mass spectrometry, according to a study published in June 2020.

The rising technological integration and automation in pharmaceutical R&D, forensic, and environmental testing rely on chromatographic systems and software for enhanced efficiency and effectiveness.

The market’s expansion is being fueled by the increased usage of analytical software for optimizing laboratory automation and the development of intelligible software and adjustable interfaces for high accuracy and productivity.

The lack of a skilled laboratory crew for chromatography software handling, on the other hand, may have a negative impact on market growth.

Due to all the factors mentioned above, the chromatography software market is expected to reach US$ 790 Mn​ in 2028.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14319

Key Takeaways:

  • In 2020, the integrated chromatography software category led the market, accounting for 76.5% of total revenue.
  • In 2020, the web and cloud-based software sector led the market, accounting for 72.1% of total revenue.
  • The pharmaceutical industry segment dominated the market in 2020, accounting for 33.4% of total sales.
  • North America dominated the market in 2020, accounting for 49.1% of total sales. The increased usage of technology in laboratory testing and policies that promote the deployment of these technologies to assure reliable results can be linked to the market’s rise.

Competitive Landscape:

Agilent Technologies, Waters Corporation, Bruker Corporation, Axel Semrau, Shimadzu Corporation, Gilson Inc., and Thermo Fisher Scientific Inc. are the leading participants in the chromatography software market. 

To maximize revenue share and boost company growth, major market participants implement strategic formulations such as forward integration, new product development, geographic expansion, and research collaborations.

Recent Developments in the Chromatography Software Market:

  • The FDA will increase Waters Corporation Empower Chromatography Data Software (CDS) to assist its medical product testing labs throughout its five field science laboratories in January 2022. This deployment will strengthen the company’s existing product line and complement the chromatography data system’s unique product portfolio, opening up new market opportunities for designing highly effective solutions for acquiring, processing, and reporting data from a wide range of measurement instruments.

Agilent Technologies released a new version of their chromatography data program in August 2018 that allows laboratories to upload documents in the Allotrope Data Format (ADF), an advanced standard developed by a group of pharmaceutical companies. The company achieved competitive advantage and strengthened its market position thanks to this strategic action.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/14319

Key Segments

By Device Type:

  • Standalone
  • Integrated

By Deployment Type:

  • On-premise
  • Web-based
  • Cloud-based

By Application:

  • Pharmaceutical Industry
  • Environmental Testing
  • Forensic Testing
  • Food & Beverages Industry
  • Others

By End Use:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Testing Facilities
  • Hospitals/Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

LinkedInTwitterBlogs

 For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

 

Editor Details

Last Updated: 13-Apr-2022